Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
February 24, 2026
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FULC
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
February 24, 2026
From
Shoals Technologies Group
Via
GlobeNewswire
Tickers
SHLS
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
February 24, 2026
From
Arvinas Inc.
Via
GlobeNewswire
Tickers
ARVN
Garrett Motion Announces Participation at the Bank of America Global Automotive Summit
February 24, 2026
From
Garrett Motion Inc.
Via
GlobeNewswire
Tickers
GTX
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
February 24, 2026
From
Monte Rosa Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GLUE
OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX
February 24, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
NRYCF
OTCM
TSX-V:NRC
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
February 24, 2026
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FHTX
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
February 24, 2026
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
AVIR
Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
February 24, 2026
From
Balchem Corporation
Via
GlobeNewswire
Tickers
BCPC
OROCO COMMENCES PHASE 2 DRILLING
February 24, 2026
From
Oroco Resource Corp.
Via
GlobeNewswire
Tickers
ORRCF
TSX-V:OCO
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
February 24, 2026
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
February 24, 2026
From
Sotera Health Services, LLC
Via
GlobeNewswire
Tickers
SHC
Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
February 24, 2026
From
Cipher Digital Inc.
Via
GlobeNewswire
Tickers
CIFR
CIFRW
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
From
Cullinan Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CGEM
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
February 24, 2026
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FULC
Autolus Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
From
Autolus Therapeutics plc
Via
GlobeNewswire
Tickers
AUTL
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
INDV
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
February 24, 2026
From
Aptose Biosciences, Inc.
Via
GlobeNewswire
Tickers
APTOF
TSX:APS
Mobilicom to Participate at Enforce Tac 2026, Germany’s Prominent Trade Fair for Security and Defense
February 24, 2026
From
Mobilicom Limited
Via
GlobeNewswire
Tickers
MOB
MOBBW
AMD and Meta Announce Expanded Strategic Partnership to Deploy 6 Gigawatts of AMD GPUs
February 24, 2026
From
Advanced Micro Devices, Inc.
Via
GlobeNewswire
Tickers
AMD
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
February 24, 2026
From
AC Immune SA
Via
GlobeNewswire
Tickers
ACIU
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
February 24, 2026
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
IOVA
OTC Markets Group Welcomes GR Silver Mining Ltd. to OTCQX
February 24, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
GRSLF
OTCM
TSX-V:GRSL
Avalo Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
From
Avalo Therapeutics
Via
GlobeNewswire
Tickers
AVTX
Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
February 24, 2026
From
Dianthus Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DNTH
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
February 24, 2026
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
February 24, 2026
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
IOVA
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
February 24, 2026
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
February 24, 2026
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AQST
OTC Markets Group Welcomes Dryden Gold Corp. to OTCQX
February 24, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
DRYGF
OTCM
TSX-V:DRY
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.